Transthyretin Amyloid Cardiomyopathy
📧 Sign up to get email alerts when something new happens for Transthyretin Amyloid Cardiomyopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-21Clinical Trial Update: A Study To Determine Any Effect Of Tafamidis On Electrocardiographic Intervals, Specifically The Rate Corrected QT Interval (QTc) [Phase 1]
Phase 1 trial evaluating whether tafamidis affects QTc intervals in transthyretin amyloid cardiomyopathy. The study has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: The Effects Of Fx-1006A On Transthyretin Stabilization And Clinical Outcome Measures In Patients With V122I Or Wild-Type TTR Amyloid Cardiomyopathy [Phase 2]
Pfizer completed a Phase 2 trial evaluating Fx-1006A for stabilizing transthyretin and improving clinical outcomes in patients with transthy…